C ognitive Effects of A typical A ntipsychotic M ed ications in P atients W ith A lzheim er's d isease: ou tcom es From C ATIE-Ad

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholinesterase inhibitors for Alzheimer ' s disease ( Review )

  2022cited by this paper
• Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.

  2008cited by this paper
• Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: Preliminary findings from a naturalistic, retrospective study

  2007cited by this paper
• Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

  2007cited by this paper
• Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

  2007cited by this paper
• Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

  2006cited by this paper
• Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

  2006cited by this paper
• Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.

  2005cited by this paper
• A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

  2005cited by this paper
• Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

  2005cited by this paper
• Olanzapine does not enhance cognition in non‐agitated and non‐psychotic patients with mild to moderate Alzheimer's dementia

  2005cited by this paper
• A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease.

  2005cited by this paper
• Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease.

  2003cited by this paper
• Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.

  2003cited by this paper
• Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.

  2001cited by this paper
• Analysis of longitudinal data in an Alzheimer's disease clinical trial.

  2000cited by this paper
• Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging.

  2000cited by this paper
• The influence of handedness on the clinical presentation and neuropsychology of Alzheimer disease.

  1999cited by this paper
• The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

  1999cited by this paper
• Analysis of error types in the trial making test evidences an inhibitory deficit in dementia of the Alzheimer type.

  1998cited by this paper
• Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs: Additions to the Alzheimer's Disease Assessment Scale That Broaden Its Scope

  1997cited by this paper
• Predicting time to nursing home care and death in individuals with Alzheimer disease.

  1997cited by this paper
• Risk of Mortality and Institutionalization in Demented Patients with Delusions

  1996cited by this paper
• A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia.

  1995cited by this paper
• Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes.

  1995cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• The brief psychiatric rating scale (BPRS) : Recent developments in ascertainment and scaling. Introduction

  1988cited by this paper
• A new rating scale for Alzheimer's disease.

  1984cited by this paper
• The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: II. Representative profile patterns.

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Development of a multilingual aphasia battery. Progress and problems.

  1969cited by this paper

• No citing papers are available for this paper.